imidazole has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhavya, K | 1 |
| Mantipally, M | 1 |
| Roy, S | 1 |
| Arora, L | 1 |
| Badavath, VN | 1 |
| Gangireddy, M | 1 |
| Dasgupta, S | 1 |
| Gundla, R | 1 |
| Pal, D | 1 |
| Tsuji, K | 1 |
| Kida, Y | 1 |
| Koshikawa, N | 1 |
| Yamamoto, S | 1 |
| Shinozaki, Y | 1 |
| Watanabe, T | 1 |
| Lin, J | 1 |
| Nagase, H | 1 |
| Takenaga, K | 1 |
2 other studies available for imidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Novel imidazo[1,2-a]pyridine derivatives induce apoptosis and cell cycle arrest in non-small cell lung cancer by activating NADPH oxidase mediated oxidative stress.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle | 2022 |
Suppression of non-small-cell lung cancer A549 tumor growth by an mtDNA mutation-targeting pyrrole-imidazole polyamide-triphenylphosphonium and a senolytic drug.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA, Mitochondrial; Humans; Imidazoles; | 2022 |